Literature DB >> 24460831

Assessment of changes in tumor heterogeneity following neoadjuvant chemotherapy in primary esophageal cancer.

C Yip1, F Davnall, R Kozarski, D B Landau, G J R Cook, P Ross, R Mason, V Goh.   

Abstract

To assess the changes in computed tomography (CT) tumor heterogeneity following neoadjuvant chemotherapy in esophageal cancer. Thirty-one consecutive patients who received neoadjuvant chemotherapy for esophageal cancer were identified. Analysis of primary tumor heterogeneity (texture) was performed on staging and post-chemotherapy CT scans. Image texture parameters (mean grey-level intensity, entropy, uniformity, kurtosis, skewness, standard deviation of histogram) were derived for different levels of image filtration (0-2.5). Proportional changes in each parameter following treatment were obtained. Comparison between pathological tumor response and texture parameters was analyzed using Mann-Whitney U-test. The relationship between CT texture and overall survival) was estimated using the Kaplan-Meier method. Tumor texture became more homogeneous after treatment with a significant decrease in entropy and increase in uniformity (filter 1.0 and 2.5). Pretreatment (filter 1.5, P = 0.006) and posttreatment standard deviation of histogram (filter 1.0, P = 0.009) showed a borderline association with pathological tumor response. A proportional change in skewness <0.39 (filter 1.0) was associated with improved survival (median overall survival 36.1 vs. 11.1 months; P < 0.001). CT tumor heterogeneity decreased following neoadjuvant chemotherapy and has the potential to provide additional information in primary esophageal cancer.
© 2014 International Society for Diseases of the Esophagus.

Entities:  

Keywords:  CT; esophageal cancer; neoadjuvant chemotherapy; prognosis; texture analysis

Mesh:

Year:  2014        PMID: 24460831     DOI: 10.1111/dote.12170

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  34 in total

1.  Computed tomography textural analysis for the differentiation of chronic lymphocytic leukemia and diffuse large B cell lymphoma of Richter syndrome.

Authors:  C P Reinert; B Federmann; J Hofmann; H Bösmüller; S Wirths; J Fritz; M Horger
Journal:  Eur Radiol       Date:  2019-06-24       Impact factor: 5.315

2.  Texture features of colorectal liver metastases on pretreatment contrast-enhanced CT may predict response and prognosis in patients treated with bevacizumab-containing chemotherapy: a pilot study including comparison with standard chemotherapy.

Authors:  Marco Ravanelli; Giorgio Maria Agazzi; Elena Tononcelli; Elisa Roca; Paolo Cabassa; Gianluca Baiocchi; Alfredo Berruti; Roberto Maroldi; Davide Farina
Journal:  Radiol Med       Date:  2019-06-06       Impact factor: 3.469

3.  Towards early monitoring of chemotherapy-induced drug resistance based on single cell metabolomics: Combining single-probe mass spectrometry with machine learning.

Authors:  Renmeng Liu; Mei Sun; Genwei Zhang; Yunpeng Lan; Zhibo Yang
Journal:  Anal Chim Acta       Date:  2019-09-25       Impact factor: 6.558

4.  CT texture analysis of pancreatic cancer.

Authors:  Kumar Sandrasegaran; Yuning Lin; Michael Asare-Sawiri; Tai Taiyini; Mark Tann
Journal:  Eur Radiol       Date:  2018-08-16       Impact factor: 5.315

Review 5.  NCTN Assessment on Current Applications of Radiomics in Oncology.

Authors:  Ke Nie; Hania Al-Hallaq; X Allen Li; Stanley H Benedict; Jason W Sohn; Jean M Moran; Yong Fan; Mi Huang; Michael V Knopp; Jeff M Michalski; James Monroe; Ceferino Obcemea; Christina I Tsien; Timothy Solberg; Jackie Wu; Ping Xia; Ying Xiao; Issam El Naqa
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-01-31       Impact factor: 7.038

6.  CT texture analysis in the differentiation of major renal cell carcinoma subtypes and correlation with Fuhrman grade.

Authors:  Yu Deng; Erik Soule; Aster Samuel; Sakhi Shah; Enming Cui; Michael Asare-Sawiri; Chandru Sundaram; Chandana Lall; Kumaresan Sandrasegaran
Journal:  Eur Radiol       Date:  2019-05-24       Impact factor: 5.315

7.  Comparison of Contrast-Enhanced CT and [18F]FDG PET/CT Analysis Using Kurtosis and Skewness in Patients with Primary Colorectal Cancer.

Authors:  Franca Wagner; Yahya Ali Hakami; Geoffrey Warnock; Gabriel Fischer; Martin W Huellner; Patrick Veit-Haibach
Journal:  Mol Imaging Biol       Date:  2017-10       Impact factor: 3.488

8.  The MR radiomic signature can predict preoperative lymph node metastasis in patients with esophageal cancer.

Authors:  Jinrong Qu; Chen Shen; Jianjun Qin; Zhaoqi Wang; Zhenyu Liu; Jia Guo; Hongkai Zhang; Pengrui Gao; Tianxia Bei; Yingshu Wang; Hui Liu; Ihab R Kamel; Jie Tian; Hailiang Li
Journal:  Eur Radiol       Date:  2018-07-23       Impact factor: 5.315

9.  Metastatic melanoma: pretreatment contrast-enhanced CT texture parameters as predictive biomarkers of survival in patients treated with pembrolizumab.

Authors:  Carole Durot; Sébastien Mulé; Philippe Soyer; Aude Marchal; Florent Grange; Christine Hoeffel
Journal:  Eur Radiol       Date:  2019-01-15       Impact factor: 5.315

10.  The emerging field of radiomics in esophageal cancer: current evidence and future potential.

Authors:  Peter S N van Rossum; Cai Xu; David V Fried; Lucas Goense; Laurence E Court; Steven H Lin
Journal:  Transl Cancer Res       Date:  2016-08       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.